Cargando…
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
BACKGROUND: Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcom...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446563/ https://www.ncbi.nlm.nih.gov/pubmed/28456509 http://dx.doi.org/10.1016/S0140-6736(17)30638-4 |
Ejemplares similares
-
The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial
por: Shakur, Haleema, et al.
Publicado: (2016) -
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
por: Shakur, Haleema, et al.
Publicado: (2010) -
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial
por: Shakur-Still, Haleema, et al.
Publicado: (2018) -
Tranexamic acid for post-partum haemorrhage: What, who and when
por: Brenner, Amy, et al.
Publicado: (2019) -
The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial
por: Brenner, Amy, et al.
Publicado: (2018)